Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06222554 · ClinicalTrials.gov registry record · NA

Examining the Use of a Novel Immersive Motion Tracking Upper Extremity Exercise Program for Acute Hospitalized Patients

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
12
Enrollment target

NCT06222554 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06222554, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

The objective of this study is to evaluate the feasibility of the MoveMend Health software program as an integrated supplement to traditional acute care/in-hospital occupational therapy for patients following liver and kidney transplants, as determined by recruitment rates, program completion, intervention adherence, safety incidence, and patient feedback on device/program performance.

Interventions

  • DEVICE MoveMend Health

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2024-08-06
Est. Completion 2024-11-27
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT06222554

The ClinicalTrials.gov registry entry for NCT06222554 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which MoveMend Health is the first listed.

NCT06222554 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06222554 about?

NCT06222554 is a clinical study titled "Examining the Use of a Novel Immersive Motion Tracking Upper Extremity Exercise Program for Acute Hospitalized Patients". The objective of this study is to evaluate the feasibility of the MoveMend Health software program as an integrated supplement to traditional acute care/in-hospital occupational therapy for patients following liver and kidney transplants, as determined by recruitment rates, program completion, inter...

What is the current status of trial NCT06222554?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2024-08-06. Estimated completion is 2024-11-27.

What interventions are being tested in trial NCT06222554?

The interventions under investigation include: MoveMend Health (DEVICE).

Who is sponsoring clinical trial NCT06222554?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.